Topics
A to Z
Data &
 Statistics
Forms &
Publications
News &
Advisories
Licensing &
Certification
Rules &
Regulations
Public Health
Directory
Print this Article   Bookmark and Share
Public Health Meaningful Use
Image of medical chart

*** NEW! *** Register your intent to submit Public Health data for MU2

Oregon providers that intend to attest for Meaningful Use Stage 2 (MU2) public health objectives are required to register their intent to do so with the Oregon Public Health Division (OPHD). Register here.
 

The Centers for Medicare and Medicaid Services (CMS) specifies the criteria that eligible professionals (EPs), eligible hospitals, and critical access hospitals (CAHs) must meet in order to continue to participate in the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs. To receive an EHR incentive payment, providers must demonstrate that they are meaningfully using (MU) their EHRs to improve patient care. Providers must meet MU Stage 1 requirements for a 90-day period in their first year and for the entire second year of meaningful use. Providers must meet Stage 2 requirements for two full years. For more information on the CMS EHR incentive program, visit www.cms.gov/EHRIncentivePrograms, or visit the Oregon Medicaid EHR Incentive Program to apply.
 

For Stage 1 in Oregon, both EPs and CAHs must submit electronic immunization data, and CAHs may also submit electronic laboratory (ELR) or syndromic surveillance data. For Stage 2, each of these is required, and EPs may also choose to submit electronic data to the cancer registry or another specialized registry (Oregon, will accept elevated blood lead levels). The table below describes submission details for each of Oregon's Public Health Meaningful Use measures. Click on the links within the table to navigate to each program and its resources.

Stage 1 Measure Stage 2 Measure Recommended Standards
Immunization Registry Reporting
1 test submission to the ALERT Immunization Information System (ALERT IIS) with continued submission if successful Ongoing submission of immunization data to ALERT IIS

ALERT IIS HL7 v2.5.1*
CVX (Data content standard)

Electronic Laboratory Reporting (ELR) 1 test submission of reportable lab results to Oregon ELR with continued submission if successful Ongoing submission of reportable lab results to Oregon ELR HL7 v2.5.1
LOINC (Data content standard)
SNOMED CT (Data content standard)
Syndromic Surveillance 1 test submission of syndromic surveillance data to Oregon ESSENCE with continued submission if successful Ongoing submission of syndromic surveillance data to Oregon ESSENCE HL7 v2.5.1
ADT Message types A01, A03, A04 and A08
PHIN Vocabulary Standards
Cancer Registry Reporting

-- N/A --
Ongoing submission of cancer data to the Oregon State Cancer Registry (OSCaR) HL7 CDA, Release 2
LOINC (Data content standard)
SNOMED CT (Data content standard)
​Other Specialized Registry**

​-- N/A --
Ongoing submission of specific case information to a specialized registry (Orpheus -- Blood Lead Reporting) HL7 v2.5.1
LOINC(Data content standard)
SNOMED CT (Data content standard)

*Providers engaged in ongoing submission of immunization data to ALERT IIS prior to Stage 1 may continue to submit earlier versions of HL7 during Stage 2.

**Oregon will accept elevated blood lead levels submitted according to the HL7 v2.5.1 ELR specifications from providers.




Computerized Entry of Laboratory Orders and Incorporation of Clinical Laboratory Results

The Oregon State Public Health Laboratory (OSPHL) is working to prioritize interface projects with the facilities that send specimens to the OSPHL. OSPHL has limited capacity to develop these interfaces, but staff are working on plans to maximize resources to support partner organizations.

When established, each interface will allow:

  • the submitter to electronically transmit laboratory test orders from their EHR to OSPHL’s laboratory information management system (LIMS), and
  • OSPHL to electronically transmit laboratory test results from OSPHL’s LIMS to the submitter's EHR.

If you are interested in electronically interfacing with the OSPHL, please send an e-mail to Sarah Humphrey, OSPHL Client Services Coordinator, at sarah.m.humphrey@state.or.us.  Please include your organization’s name, contact information for the key contact at your organization, and the EMR system your organization uses.


Both computerized provider order entry of laboratory tests and incorporation of clinical laboratory results are required MU objectives in Stage 2, and successful interfaces will meet these objectives. However, with the aforementioned limited resources, these interfaces may not be able to be established within your reporting period and you may need to establish this interface with another organization for MU purposes.